| Literature DB >> 31600769 |
Julie A Hofheimer1, Lynne M Smith2, Elisabeth C McGowan3, T Michael O'Shea4, Brian S Carter5, Charles R Neal6, Jennifer B Helderman7, Steven L Pastyrnak8, Antoine Soliman9, Lynne M Dansereau10, Sheri A DellaGrotta10, Barry M Lester3,10,11.
Abstract
BACKGROUND: Psychosocial adversity escalates medical risk for poor outcomes in infants born <30 weeks gestation. Neonatal neurobehavior and maternal psychological and socioenvironmental assessments may identify the earliest specific intervention needs. We hypothesized that maternal prenatal anxiety, depression, and adverse medical and socioenvironmental conditions would be associated with less optimal neonatal neurobehavior at neonatal intensive care unit (NICU) discharge.Entities:
Mesh:
Year: 2019 PMID: 31600769 PMCID: PMC7082182 DOI: 10.1038/s41390-019-0607-1
Source DB: PubMed Journal: Pediatr Res ISSN: 0031-3998 Impact factor: 3.756
Figure 1:Study Flow and Eligibility
Multivariable GEE Significance Tests
| Prenatal Anxiety[ | Prenatal Depression[ | |||||
|---|---|---|---|---|---|---|
| NNNS Summary Score and Predictors | B | SE | Adjusted Means Anxiety ; No Anxiety | B | SE | Adjusted Means Depression; No Depression |
| −0.43 | 0.18 | 4.88 ; 5.31 | −0.45 | 0.29 | 4.86 ; 5.31 | |
| Neonatal Medical Complications | −0.36 | 0.07 | −0.36 | 0.07 | ||
| PMA at Exam | 0.31 | 0.08 | 0.31 | 0.08 | ||
| −0.02 | 0.04 | 0.39 ; 0.41 | −0.06 | 0.04 | 0.35 ; 0.41 | |
| PMA at Exam | −0.03 | 0.01 | −0.03 | 0.01 | ||
| −0.02 | 0.12 | 4.57 ; 4.59 | −0.18 | 0.13 | 4.41 ; 4.60 | |
| Socioenvironmental Risk | −0.08 | 0.03 | −0.07 | 0.03 | ||
| −0.10 | 0.13 | 5.53 ; 5.62 | −0.29 | 0.16 | 5.34 ; 5.63 | |
| Socioenvironmental Risk | −0.07 | 0.03 | −0.07 | 0.03 | ||
| −0.06 | 0.35 | 2.44 ; 2.50 | 0.34 | 0.43 | 2.81 ; 2.48 | |
| PMA at Exam | 0.25 | 0.11 | 0.26 | 0.11 | ||
| 0.50 | 0.28 | 5.01 ; 4.51 | 1.01 | 0.41 | 5.49 ; 4.49 | |
| Neonatal Medical Complications | 0.36 | 0.10 | 0.35 | 0.11 | ||
| PMA at Exam | −0.30 | 0.11 | −0.30 | 0.11 | ||
| −0.04 | 0.09 | 3.71 ; 3.75 | −0.08 | 0.13 | 3.67 ; 3.75 | |
| PMA at Exam | 0.08 | 0.03 | 0.08 | 0.03 | ||
| −0.01 | 0.01 | 0.13 ; 0.14 | −0.01 | 0.01 | 0.13 ; 0.14 | |
| Substance Use Index | −0.01 | 0.003 | −0.01 | 0.003 | ||
| 0.14 | 0.14 | 0.50 ; 0.36 | 0.15 | 0.15 | 0.51 ; 0.36 | |
| PMA at Exam | 0.11 | 0.04 | 0.11 | 0.04 | ||
| - | - | −0.02 | 0.07 | 0.21 ; 0.23 | ||
| Substance Use Index | - | - | −0.03 | 0.01 | ||
| 0.19 | 0.28 | 5.55 ; 5.36 | −0.11 | 0.35 | 5.27 ; 5.38 | |
| Neonatal Medical Complications | 0.33 | 0.10 | 0.33 | 0.10 | ||
| Maternal Medical Risk | 0.20 | 0.09 | 0.20 | 0.09 | ||
| 0.04 | 0.19 | 1.01 ; 0.97 | −0.08 | 0.19 | 0.90 ; 0.98 | |
Notes: Significant predictors are tabled for *p<.05, **p<.01 with Bonferroni correction for multiple tests. Separate models testing anxiety and depression examined associations with all of the following: neonatal medical risk, maternal medical risk, socioenvironmental risk, and PMA at NNNS exam, after adjusting for site.
Model did not converge.
There were no significant associations between NNNS scores and prenatal use of prescribed antidepressant or anxiolytic medication.
Sample Descriptive Statistics for NNNS Summary Scores1
| NNNS Summary Score (N) | Mean | SD | Min-Max Range | Percentiles | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 5th | 10th | 25th | 50th | 75th | 90th | 95th | ||||
| 5.29 | 1.50 | 1.00-9.00 | 3.00 | 3.43 | 4.14 | 5.14 | 6.50 | 7.43 | 7.71 | |
| 0.41 | 0.27 | 0.00-1.00 | 0 | 0 | 0.25 | 0.38 | 0.63 | 0.75 | 0.88 | |
| 4.59 | 0.69 | 2.00-6.40 | 3.40 | 3.67 | 4.17 | 4.67 | 5.00 | 5.40 | 5.60 | |
| 5.62 | 0.80 | 2.64-7.82 | 4.27 | 4.60 | 5.14 | 5.62 | 6.08 | 6.63 | 6.92 | |
| 2.48 | 2.07 | 0.00-10.0 | 0 | 0 | 1.00 | 2.00 | 3.00 | 5.00 | 7.00 | |
| 4.55 | 2.11 | 0.00-15.0 | 2.00 | 2.00 | 3.00 | 4.00 | 6.00 | 7.00 | 9.00 | |
| 3.74 | 0.65 | 1.71-5.86 | 2.71 | 3.00 | 3.29 | 3.71 | 4.14 | 4.57 | 4.86 | |
| 0.14 | 0.07 | 0.00-0.39 | 0.02 | 0.04 | 0.08 | 0.12 | 0.18 | 0.24 | 0.27 | |
| 0.38 | 0.74 | 0.00-5.00 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | 2.00 | |
| 0.22 | 0.51 | 0.00-4.00 | 0 | 0 | 0 | 0 | 0 | 1.00 | 1.00 | |
| 0.97 | 1.29 | 0.00-6.00 | 0 | 0 | 0 | 0 | 2.00 | 3.00 | 4.00 | |
| 5.36 | 2.06 | 0.00-11.0 | 2.00 | 3.00 | 4.00 | 5.00 | 7.00 | 8.00 | 9.00 | |
Habituation was not able to be administered for infants initially in awake states, and was not included in analyses.
Figure 2:Conceptual Model of Influences on Neurobehavioral Constructs at NICU Discharge
Maternal and Neonatal Characteristics and Risk Indices
| Maternal Psychosocial and Medical Characteristics (n=583) | N (%) or Mean (SD) |
|---|---|
| 1.1 (0.91) | |
| Minority race or ethnicity | 333 (57.1) |
| Maternal age > 35 at childbirth | 104 (17.8) |
| No prenatal care | 16 (2.7) |
| No partner | 145 (24.9) |
| Low socioeconomic status (Hollingshead category 5) | 55 (9.4) |
| 0.94 (0.87) | |
| Diabetes mellitus or gestational diabetes | 36 (6.2) |
| Pregnancy infection (vaginal, cervical, urinary, or kidney) | 60 (10.3) |
| Hypertension (chronic or pregnancy induced) | 159 (27.3) |
| HIV/AIDS, other sexually transmitted infections | 38 (6.5) |
| Pre-pregnancy obesity, BMI>30 | 198 (34.0) |
| Pre-pregnancy underweight, BMI<18.5 | 29 (5.0) |
| Congenital anomaly (not affecting NNNS administration) | 33 (5.7) |
| 0.30 (0.68) | |
| Tobacco | 84 (14.4) |
| Alcohol | 19 (3.3) |
| Marijuana | 57 (9.8) |
| Other recreational substance use | 26 (4.5) |
| Opiates | 14 (2.4) |
| Stimulants | 13 (2.2) |
| Benzodiazepines/Barbiturates | 5 (0.97) |
| Hallucinogens | 2 (0.3) |
| Prenatal depression | 35 (6.0) |
| Prescribed antidepressants during pregnancy | 30 (5.1) |
| Depression counseling during pregnancy | 25 (4.3) |
| Prenatal anxiety | 42 (7.2) |
| Prescribed anxiolytics during pregnancy | 31 (5.3) |
| Anxiety counseling during pregnancy | 31 (5.3) |
| Neonatal Medical Characteristics (N=665) | N (%) or Mean(SD) |
| Female | 291 (43.8) |
| Cesarean Delivery | 471 (70.8) |
| Multiple Gestation | 176 (26.5) |
| PMA at birth (weeks) | 27.0 (1.9) |
| ≤25 | 140 (21.1) |
| >25 to ≤28 | 299 (45.0) |
| >28 to <30 | 226 (34.0) |
| Birthweight (grams) | 951.6(278.6) |
| Head Circumference | 24.5 (2.4) |
| Intrauterine Growth Restriction (birthweight <10%ile for PMA) | 48 (7.2) |
| PMA at NNNS exam (range 32.1-51.3 weeks) | 39.3 (3.4) |
| <34 weeks | 6 (0.9) |
| ≥34 to <36 weeks | 98 (14.7) |
| ≥36 to <38 weeks | 167 (25.1) |
| ≥38 to <42 weeks | 259(38.9) |
| ≥42 to <46 weeks | 96 (14.4) |
| ≥ 46 weeks | 39(5.9) |
| PMA at NICU Discharge | 40.4 (5.1) |
| Length of NICU Stay (Days) | 93.3 (42.4) |
| Out-born | 128 (19.2) |
| 0.87(0.87) | |
| Severe Retinopathy of Prematurity | 40 (6.0) |
| Sepsis | 87 (13.1) |
| Necrotizing enterocolitis | 44 (6.6) |
| Chronic Lung Disease | 336 (50.5) |
| Severe Brain Injuries (parenchymal echodensity, periventricular leukomalacia, ventricular dilatation) | 146 (22.0) |
| Parenchymal echodensity on any scan | 52 (7.8) |
| Periventricular leukomalacia on any scan | 43 (6.5) |
| Periventricular leukomalacia on late scan | 26 (3.9) |
| Germinal matrix hemorrhage on any scan | 149 (22.4) |
| Intraventricular hemorrhage on any scan | 119 (17.9) |
| Intraventricular hemorrhage on late scan | 69 (10.4) |
| Ventricular dilatation on any scan | 51 (7.7) |
| Ventricular dilatation on late scan | 40 (6.0) |
| Intracerebral hemorrhage on any scan | 3 (0.5) |
| Cerebellar hemorrhage on any scan[ | 12 (1.8) |
Note: NNNS, NICU Network Neurobehavioral Scale (NNNS);
Brain injuries included in the Neonatal Medical Complications Index;
Lower than expected rate in this <30 week PMA sample may be due to the absence of mastoid CUS views